Highlights from the 22nd International AIDS Conference (AIDS 2018), 22-27 July 2018, Amsterdam, the Netherlands
- PMID: 30515304
- PMCID: PMC6248835
- DOI: 10.1016/S2055-6640(20)30310-1
Highlights from the 22nd International AIDS Conference (AIDS 2018), 22-27 July 2018, Amsterdam, the Netherlands
Abstract
Important data on the social, epidemiological and clinical aspects of HIV-1, comorbidities and hepatitis as well as data on novel antiretroviral agents and the cure agenda were presented at AIDS 2018. This report covers some of the highlights.
Figures
References
-
- Rodger A, Cambiano V, Bruun T et al. . Risk of HIV transmission through condomless sex in gay couples with suppressive ART: the PARTNER2 study expanded results in gay men. Abstract WEAX0104LB.
-
- Crowford S, Miller R, Post F et al. . Mortality and cause of death among HIV patients in London in 2016. Abstract TUPDC0106. - PubMed
-
- Magnuson D, Hawkins T, Mera R. Adolescent use of Truvada (FTC/TDF) for HIV pre-exposure prophylaxis (PrEP) in the United States (2012–2017). Abstract TUAC0305.
-
- Ananworanich J, Pinyakorn S, Avihingsanon A et al. . Favorable clinical phenotype reached in less than half of people treated in acute HIV infection. Abstract WEPDB0102.
-
- Tremeaux P, Lenfant T, Boufassa F et al. . Increasing contribution of integrated forms to total HIV1-DNA in blood, in primary infection during natural history - ANRS PRIMO and SEROCO cohorts. Abstract WEPDB0103.
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources